DU PONT E I DE NEMOURS & CO INC -- SUVA MP 39,8951-3130,R-401 A -- 6830-01-391-3101 
=====================  Product Identification  =====================

Product ID:SUVA MP 39,8951-3130,R-401 A
MSDS Date:08/31/1988
FSC:6830
NIIN:01-391-3101
=== Responsible Party ===
Company Name:DU PONT E I DE NEMOURS & CO INC
Address:1007 MARKET STREET
City:WILMINGTON
State:DE
ZIP:19898
Country:US
Info Phone Num:800-441-9442
Emergency Phone Num:800-441-3637/800-424-9300(CHEMTREC)
CAGE:18873
=== Contractor Identification ===
Company Name:DU PONT FLUOROPRODUCTS
Address:1007 MARKET STREET
Box:City:WILMINGTON
State:DE
ZIP:19898
Country:US
Phone:1-800-441-7515
CAGE:2S827
Company Name:E.I. DUPONT DE NEMOURS & CO
Address:1007 MARKET STREET
Box:City:WILMINGTON
State:DE
ZIP:19898
Country:US
Phone:800-441-7515;800-441-9442
CAGE:18873

=============  Composition/Information on Ingredients  =============

Ingred Name:CHLORODIFLUOROMETHANE (SARA 313) (CERCLA)
CAS:75-45-6
RTECS #:PA6390000
Fraction by Wt: 52%
Other REC Limits:NONE RECOMMENDED
OSHA PEL:1000 PPM
ACGIH TLV:1000 PPM; 9495
Ozone Depleting Chemical:2

Ingred Name:2-CHLORO-1,1,1,2-TETRAFLUOROETHANE (SARA 313)
CAS:2837-89-0
Fraction by Wt: 33%
Other REC Limits:NONE RECOMMENDED

Ingred Name:ETHANE, 1,1-DIFLUORO
CAS:75-37-6
RTECS #:KI1410000
Fraction by Wt: 15%
Other REC Limits:NONE RECOMMENDED

=====================  Hazards Identification  =====================

LD50 LC50 Mixture:INHALE 4-HOUR LC50: 220,000 IN RATS.
Routes of Entry: Inhalation:YES  Skin:NO  Ingestion:NO
Reports of Carcinogenicity:NTP:NO    IARC:NO	OSHA:NO
Health Hazards Acute and Chronic:TARGET ORGANS:LUNGS, CNS. ACUTE-
    INHALATION OF HIGH CONCENTRATIONS OF VAPOR MAY CAUSE HEART
    IRREGULARITIES, UNCONSCIOUSNESS/DEATH. INTENTIONAL MISUSE IS FATAL.
    VAPOR REDUCES OXYGEN & IS HEAVIER THAN A IR. EYE/SKIN CONTACT WITH
    LIQUID CAN CAUSE FROSTBITE. VAPORS MAY CAUSE EYE IRRITATION.
    INGESTION NOT LIKELY. CHRONIC-UNK
Explanation of Carcinogenicity:NONE
Effects of Overexposure:TEMPORARY NERVOUS SYSTEM DEPRESSION WITH
    ANAESTHETIC EFFECTS SUCH AS DIZZINESS, HEADACHE, CONFUSION,
    INCOORDINATION, LOSS OF CONSCIOUSNESS, IRREGULAR PULSE,
    PALPITATIONS, INADEQUATE CIRCULATION, SKIN	FROSTBILTE, EYE
    IRRITATION
Medical Cond Aggravated by Exposure:INDIVIDUALS WITH PREEXISTING
    DISEASES OF THE CENTRAL NERVOUS OR CARDIOVASCULAR SYSTEM MAY HAVE
    INCREASED SUSCEPTIBILITY TO THE TOXICITY OF EXCESSIVE EXPOSURE.

=======================  First Aid Measures  =======================

First Aid:GET MEDICAL ATTENTION IF NEEDED. EYE/SKIN:IMMEDIATELY FLUSH
    WITH PLENTY OF WATER. TREAT FOR FROSTBITE, IF NECESSARY.
    INHALED:REMOVE TO FRESH AIR & PROVIDE OXYGEN/CPR IF NEEDED.
    ORAL:INGESTION IS NOT C ONSIDERED A POTENTIAL ROUTE OF EXPOSURE.

=====================  Fire Fighting Measures  =====================

Flash Point:NONE
Lower Limits:WATER SPRAY,
Extinguishing Media:WATER SPRAY, CARBON DIOXIDE, FOAM OR DRY CHEMICAL
    FOR SURROUNDING FIRE. USE WATER SPRAY TO COOL FIRE EXPOSED
    CONTAINERS.
Fire Fighting Procedures:WEAR FULL PROTECTIVE CLOTHING AND
    NIOSH-APPROVED SELF-CONTAINED BREATHING APPARATUS WITH FULL
    FACEPIECE OPERATED IN THE POSITIVE PRESSURE MODE.
Unusual Fire/Explosion Hazard:THIS PRODUCT CAN BE DECOMPOSED BY HIGH
    TEMPERATURES (OPEN FLAMES, GLOWING METALS) FORMING HYDROGEN
    FLUORIDE, HYDROGEN CHLORIDE AND TRACES OF CARBONYL HALIDES.

==================  Accidental Release Measures  ==================

Spill Release Procedures:VENTILATE AREA, ESPECIALLY LOW PLACES WHERE
    VAPORS MIGHT COLLECT. REMOVE OPEN FLAMES. USE SELF-CONTAINED
    BREATHING APPARATUS FOR LARGE SPILLS OR RELEASES.
Neutralizing Agent:NOT RELEVANT

======================	Handling and Storage  ======================

Handling and Storage Precautions:STORE IN A COOL, DRY, WELL VENTILATED
    AREA, AWAY FROM HEAT AND FLAMES. DO NOT HEAT ABOVE 125F.
Other Precautions:AVOID BREATHING VAPORS. AVOID EYE OR SKIN CONTACT.
    WASH WITH SOAP AND WATER BEFORE EATING OR DRINKING. USE WITH
    ADEQUATE VENTILATION. NEVER USE IN CONFINED OR CLOSED SPACES
    WITHOUT PROPER PROTECTIVE E QUIPMENTS.

=============  Exposure Controls/Personal Protection  =============

Respiratory Protection:WEAR NIOSH-APPROVED SELF-CONTAINED BREATHING
    APPARATUS OPERATED IN POSITIVE PRESSURE MODE OR SUPPLIED-AIR
    RESPIRATOR WITH FULL FACEPIECE AND OPERATED IN PRESSURE-DEMAND OR
    OTHER POSITIVE PRESSURE MODE  IF A LARGE RELEASE OCCURS.
Ventilation:NORMAL VENTILATION IS SUFFICIENT. LOCAL EXHAUST WHEN LARGE
    AMOUNTS ARE RELEASED, MECHANICAL VENTILATION IN LOW PLACES
Protective Gloves:LINED BUTYL GLOVES
Eye Protection:CHEMICAL SPLASH GOGGLES/FACE SHIELD
Other Protective Equipment:EYEBATH, SAFETY SHOWER, PROTECTIVE CLOTHING
Work Hygienic Practices:OBSERVE GOOD PERSONAL HYGIENE PRACTICES AND
    RECOMMENDED PROCEDURES. DO NOT WEAR CONTAMINATED CLOTHING.
Supplemental Safety and Health
NOTE TO PHYSICIAN:BECAUSE OF POSSIBLE DISTURBANCES OF CARDIAC RHYTHM,
    CATECHOLAMINE DRUGS, SUCH AS EPINEPHRINE, SHOULD BE USED WITH
    SPECIAL CAUTION ONLY IN SITUATIONS OF EMERGENCY LIFE SUPPORT.

==================  Physical/Chemical Properties  ==================

HCC:G3
NRC/State Lic Num:NOT RELEVANT
Boiling Pt:B.P. Text:-27F,-33C
Vapor Pres:5749 @77F
Spec Gravity:1.188 LIQUID
Viscosity:NOT RELEVANT
Evaporation Rate & Reference:>1 (CCL4 = 1)
Solubility in Water:0.1% @ 77F (25C)
Appearance and Odor:CLEAR, COLORLESS LIQUEFIED GAS - SLIGHT ETHEREAL
    ODOR
Percent Volatiles by Volume:100

=================  Stability and Reactivity Data  =================

Stability Indicator/Materials to Avoid:YES
ALKALI OR ALKALINE EARTH METALS, POWDERED ALUMINUM, ZINC, BERYLLIUM,
    ETC.
Stability Condition to Avoid:OPEN FLAMES, EXCESSIVE HEAT, GLOWING METAL
    SURFACES
Hazardous Decomposition Products:MAY FORM HYDROGEN FLUORIDE, HYDROGEN
    CHLORIDE AND TRACES OF CARBONYL HALIDES.

====================  Disposal Considerations  ====================

Waste Disposal Methods:RECLAIM BY DISTILLATION OR REMOVE TO PERMITTED
    WASTE DISPOSAL FACILITY. CONSULT LOCAL, STATE AND FEDERAL
    AUTHORITIES.

 Disclaimer (provided with this information by the compiling agencies):
 This information is formulated for use by elements of the Department
 of Defense.  The United States of America in no manner whatsoever,
 expressly or implied, warrants this information to be accurate and
 disclaims all liability for its use.  Any person utilizing this
 document should seek competent professional advice to verify and
 assume responsibility for the suitability of this information to their
 particular situation.